CNE100006XS6
CNE100006XS6
HENGRUI PHARMA
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 318.59B EUR | 383.96B EUR | 428.1B EUR |
Enterprise Value | 328.81B EUR | 345.3B EUR | 387.64B EUR |
Valuation Multiples | |||
Trailing P/E | 36.92x | 42.66x | 49.25x |
Forward P/E | 28.65x | -- | -- |
Price to Sales | 9.78x | 11.83x | 13.24x |
Price to Book | 4.36x | 5.96x | 6.73x |
EV/Revenue | 10.1x | 10.64x | 11.99x |
EV/EBITDA | 34.78x | 37.36x | 40x |
Price to FCF (P/FCF) | 50.51x | 85.96x | 107.24x |
EV/FCF | 52.13x | 77.3x | 97.1x |
FCF Yield | 1.98% | 1.16% | 0.93% |